RETRACTED ARTICLE: Release-Active Dilutions of Diclofenac Enhance Anti-inflammatory Effect of Diclofenac in Carrageenan-Induced Rat Paw Edema Model

Abstract

The study was aimed to investigate the effect of technologically treated diclofenac (release-active dilutions of diclofenac (RAD of diclofenac)) on anti-inflammatory activity of diclofenac in carrageenan-induced rat paw edema model. Ninety male Wistar albino rats (6–8 weeks) divided into nine groups (n = 10) were used. Anti-inflammatory activity was assessed at 1, 2, 3, 4, and 6 h after subplantar injection of carrageenan (0.1 ml of a 1 % solution in normal saline). Diclofenac alone was studied at 5 and 20 mg/kg, RAD of diclofenac alone at 7.5 ml/kg and their combination at 5 and 7.5 ml/kg, respectively. Diclofenac reduced (p < 0.05 at least) paw edema at all time points. RAD of diclofenac enhanced (p < 0.05) anti-inflammatory effect of diclofenac (5 mg/kg) at 2, 4, and 6 h on concurrent and at 2 and 4 h on sequential administration. Moreover at 2 h, anti-inflammatory effect of combination treatment reached values comparable to those of diclofenac (20 mg/kg). In conclusion, RAD of diclofenac enhanced anti-inflammatory effect of diclofenac.

The Spatial Homeostasis Hypothesis

“…In a series of experiments, animals were co-administered a "high" (either a therapeutic or even toxic) dose of a common drug, such as prednisolone, haloperidol, phenazepam, diclofenac or cyclophosphamide, together with a "high dilution" of the same drug. The results showed that in the presence of its "high dilution", the activity of the drug was positively modified, enhancing pharmacological effects and reducing toxicity [37][38][39][40][41][42][43][44][45][46][47][48].…”

Liquid phase based separation systems for depletion, prefractionation, and enrichment of proteins in biological fluids and matrices for in‐depth proteomics analysis—An update covering the period 2011–2014

“…In another study, LAPs from serum sample of early rheumatoid arthritis (RA) patients and healthy controls were enriched using ProteoMiner™ technology [38]. The enriched proteins were separated on SDS-PAGE, digested by trypsin, labelled with tandem mass tag reagents, and desalted by C18 stage tip column.…”

Naringin Loaded Chitosan Nanoparticle for Bone Regeneration: A Preliminary in vitro Study

“…Heat induced haemolysis: The percentage inhibition of the antiinflammatory activity of the drug was determined and calculated by the below mentioned formula [6]. Inhibition of albumin denaturation: The percentage inhibition of the albumin denaturation was calculated as follows [6]. All three test tubes were incubated at room temperature for 15 minutes.…”

“…Chitosan serves as a promising permeation enhancer and mucoadhesive. Drugs can be encapsulated using chitosan along with Sodium-Tripoly phosphate (TPP) which acts as a cross linker [6].…”